Linda بالحاج bel hadj kacem

Dr. Linda بالحاج bel hadj kacem

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2024 in Biology
Verified
Journal Article
Open access
PDF file
TATakoua Ben attia
Takoua Ben attia
SBSana Bahri
Sana Bahri
SYSonia BEN YOUNES
Sonia BEN YOUNES
ANAfef Nahdi
Afef Nahdi
RARidha Ben Ali
Ridha Ben Ali
AMAbada MHAMDI
Abada MHAMDI
The primary objective of this study was to investigate the pulmonary damage resulting from isolated or combined exposure to inhaled toluene (300 ppm) and noise 85 dB (A), with a focus on evaluating the potential protective effects of Olea europaea L. leaf extract (OLE). Forty-eight male Wistar rats were divided into eight groups: control (C), OLE treatment (O), noise exposure (N), noise exposure with OLE treatment (N+OLE), toluene exposure (T), toluene exposure with OLE treatment (T + OLE), co-exposure to toluene and noise (NT), and co-exposure with OLE treatment (NT + OLE). OLE (40 mg/kg/day) was administered daily for six weeks via oral gavage. Exposure to toluene and noise resulted in significant disruption of the pulmonary tissue structure, accompanied by oxidative stress, as evidenced by increased lipid peroxidation, diminished catalase and superoxide dismutase activities, and elevated pro-inflammatory cytokines IL6, IL-β, and TNF-α. Notably, the administration of OLE effectively mitigated oxidative stress and inflammation and preserved pulmonary histology. In conclusion, exposure to toluene and its combination with noise significantly elevated oxidative stress, inflammatory responses, and histological disruptions in the lung tissue. In contrast, noise exposure alone is characterized by minimal effects, although it is still associated with an inflammatory response. Notably, Olea europaea L. leaf extract (OLE) exhibits a substantial protective role, effectively mitigating the adverse effects of combined exposure and highlighting its potential as a therapeutic agent for lung health.

2 June 2025 in F1000Research
Verified
Journal Article
Open access
PDF file
MBmalek bouhani
malek bouhani
OJOlfa Jaidane
Olfa Jaidane
HBHanen Bouaziz
Hanen Bouaziz
LKLinda بالحاج bel hadj kacem
Linda بالحاج bel hadj kacem
GSGhada Sahroui
Ghada Sahroui
TDTarek Ben Dhiab
Tarek Ben Dhiab
Background Breast cancer in elderly patients, particularly in centenarians, presents unique diagnostic and therapeutic challenges. Encapsulated papillary carcinoma (EPC) is a rare subtype that typically exhibits indolent behavior, but its aggressive course remains poorly understood. This report describes an exceptional case of EPC in a 102-year-old woman with a rapid metastatic progression. Case Presentation A 102-year-old female with hypertension presented with a one-year history of a progressively enlarging, left-sided breast mass. Imaging revealed a 28 cm cystic mass with a 14 cm intracystic nodule. Biopsy confirmed ER-positive, PR-negative, HER2-negative encapsulated papillary carcinoma (T3N0M0). Mastectomy with axillary dissection revealed a 13 cm tumor with close surgical margins (<0.5 mm). The final histologic examination concluded to a pure EPC. Three months postoperatively, metastatic lesions in the sternum and liver were identified. Despite initiating letrozole and CDK4/6 inhibitor therapy, the patient succumbed to cardiac arrest. Conclusion The case of a 102-year-old female with EPC of the breast illustrates several unique and clinically significant features, including the rarity of metastasis, exceptional tumor size, and implications of advanced age on the disease course and management. This case study in accordance with the CARE guidelines.

27 September 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
LRLeila Rouached
Leila Rouached
EHEmna Hannech
Emna Hannech
RJRiadh Jeribi
Riadh Jeribi
OSOlfa Saidane
Olfa Saidane
ATAicha Ben Tekaya
Aicha Ben Tekaya
LALeila Abdelmoula
Leila Abdelmoula

26 April 2022
Verified
Preprint
Open access
PDF file
NLNoureddine Litaiem
Noureddine Litaiem
FKFerdaous Khammouma
Ferdaous Khammouma
MMMalek Mrad
Malek Mrad
TBTakwa Bacha
Takwa Bacha
LKLinda بالحاج bel hadj kacem
Linda بالحاج bel hadj kacem
FZFaten Zeglaoui
Faten Zeglaoui
We report a case of a 41-year-old male patient with no family history, presented with extensive multiple keratoacanthomas with disfiguring scars. The diagnosis of a sporadic form of Ferguson-Smith syndrome was made. Treatment with acitretin showed a marked response. Recognizing this syndrome is crucial, early treatment helps avoid scar format

25 August 2025 in Cancers
Verified
Journal Article
Open access
PDF file
NBNouha Setti Boubaker
Nouha Setti Boubaker
Aymone GurtnerAymone Gurtner
Aymone Gurtner
SBSami Boussetta
Sami Boussetta
IMIsabella Manni
Isabella Manni
ASAhmed Saadi
Ahmed Saadi
GPGiulia Piaggio
Giulia Piaggio
Background: Despite clinical and pathological risk tools, predicting outcomes in non-muscle-invasive bladder cancer (NMIBC), particularly high-grade (HG) cases, remains challenging due to its unpredictable recurrence and progression. There is an urgent need for molecular biomarkers to enhance risk stratification and guide treatment. Methods: We assessed the prognostic potential of eight miRNAs (miR-9, miR-143, miR-182, miR-205, miR-27a, miR-369, let-7c, and let-7g) in a cohort of ninety patients with primary bladder cancer. Expression data were retrieved from our previously published studies. Kaplan–Meier’s and Cox’s regression analyses were used to evaluate the associations with overall survival (OS), metastasis-free survival (MFS), and clinical outcomes. Principal component analysis (PCA) was performed to identify informative miRNA combinations. Target gene prediction, pathway enrichment (DAVID), and drug–gene interaction mapping (DGIdb) were conducted in silico. Results: A high expression of let-7g and miR-9 was significantly associated with better OS in HG NMIBC and MIBC, respectively (p = 0.013 and p = 0.000). MiR-9 downregulation correlated with metastasis in MIBC (p = 0.018). Among all combinations, miR-205 and miR-27a best predicted intermediate-risk NMIBC progression and recurrence (r2 = 0.982, p = 0.000). A functional analysis revealed that these miRNAs regulate key cancer-related pathways (MAPK, mTOR, and p53) through genes such as TP53, PTEN, and CDKN1A. Drug interaction mapping identified nine target genes (e.g., DAPK1, ATR, and MTR) associated with eight FDA-approved bladder cancer therapies, including cisplatin and gemcitabine. Conclusions: Let-7g, miR-9, miR-143, miR-182, and miR-205 emerged as promising biomarkers for outcome prediction in NMIBC. Their integration into liquid biopsy platforms could support non-invasive monitoring and personalized treatment strategies. These findings warrant validation in larger, prospective studies and through functional assays.